News

Mor Research Applications

Met Mor’s team at Mixiii 2024, March 5-6, Jerusalem

Companies, entrepreneurs and investors please contact: sari@mor-research.com

NGS Solutions

NGS’ Healthy Heights Available at Walmart

Walmart now stocking Healthy Heights with significant opportunities for expansion

Mor Research Applications

IIA invests 25M NIS in innovation center in Be’er Sheva

Synergy 7 jointly owned by Mor, Ben Gurion U, B.G. Negev, Soroka , Elbit , Incubit Technological Entrepreneurship and Merage

Exero Medical

Exero’s Pivotal Clinical Study Approved by WCG

Exero’s multi-center study expected to commence during Q1 2024.

Can-Fite

CAN-FITE expands license deal with Ewopharma

Exclusive distribution agreement for psoriasis and hepatocellular carcinoma (HCC) and nonalcoholic steatohepatitis (NASH).

Mediwound

Mediwound announces positive data from clinical study

Phase I/II study evaluated safety and efficacy of MW005 for low-risk Basal Cell Carcinoma (BCC).

Cathworks

Cathworks announces first patient in clinical trial

Evaluates the clinical benefits of FFRangio® System in coronary artery disease (CAD)

Nanox

Nanox.AI New Global Partnership with Ferrum Health

Partnership on AI platform – Bone solution (HealthOST) and cardiac solution (HealthCCSng)

Exero

Unorthodox Ventures Invests in Exero Medical

Unorthodox and Founder Carey Smith provide bridge financing toward a series A round

DiA

DiA Secures FDA Clearance for its New AI Software

LVivo IQS for cardiac ultrasound users with real-time image quality feedback while scanning

123